Clinical Trial Update: Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update comparing adjuvant gemcitabine plus oxaliplatin versus gemcitabine plus cisplatin in patients with completely resected stage IB/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Lung Cancer | Phase 2 | Status: UNKNOWN